TAVR | tctmd.com

Presentation

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll,

October 06, 2017

Presentation TCT 2017

REPRISE III: Critique and Unanswered Questions

Presenter: Davide Capodanno

November 01, 2017

Presentation TCT 2017

REPRISE III: Topline Findings and Practice Implications

Presenter: Ted Feldman

November 01, 2017

Presentation TCT 2017

SURTAVI Trial Critique and Unanswered Questions

Presenter: E. Murat Tuzcu

November 01, 2017

Presentation TCT 2017

SURTAVI: Topline Findings and Practice Implications

Presenter: Nicolas M. Van Mieghem

November 01, 2017

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

By Caitlin E. Cox

August 31, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

By Michael O'Riordan

August 31, 2017

Presentation SOLACI 2017

PCI & TAVR

Presenter: Conrad Simpfendorfer

August 02, 2017

Presentation SOLACI 2017

Role of Embolic Protection during TAVR

Presenter: Samir Kapadia

August 02, 2017

Subscribe to TAVR

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.